Pure Global
NCT06311292

Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis

Pilot Study of Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis
Daniel J. Weiner·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cystic Fibrosis
Drug/Device/Intervention
Volara System
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Daniel J. Weiner
Funder
University of Pittsburgh
Location
Pittsburgh, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Jun 01, 2025
Enrollment
20 participants
Primary outcome

Sufficient sputum quantity for a pellet

Summary

This is a small pilot study with the goal of identifying a superior sputum collection method
 in Cystic Fibrosis patients unable to produce a sputum.
 
 Participants will use the Volara System during clinic visit in an attempt to produce sputum.

ICD-10 classifications
Cystic fibrosisCystic fibrosis, unspecifiedCystic fibrosis with other manifestationsCystic fibrosis with pulmonary manifestationsCystic fibrosis with intestinal manifestations
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06311292
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06311292 through Pure Global AI's free database. This phase not specified trial is sponsored by Daniel J. Weiner and is currently Recruiting. The study focuses on Cystic Fibrosis. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.